Outcomes After Stopping Tyrosine Kinase Inhibitors in Patients With Chronic Myeloid Leukemia
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Assessment of Outcomes After Stopping Tyrosine Kinase Inhibitors Among Patients With Chronic Myeloid Leukemia: A Nonrandomized Clinical Trial
JAMA Oncol 2020 Nov 12;[EPub Ahead of Print], E Atallah, CA Schiffer, JP Radich, KP Weinfurt, MJ Zhang, J Pinilla-Ibarz, V Kota, RA Larson, JO Moore, MJ Mauro, MWN Deininger, JE Thompson, VG Oehler, M Wadleigh, NP Shah, EK Ritchie, RT Silver, J Cortes, L Lin, A Visotcky, A Baim, J Harrell, B Helton, M Horowitz, KE FlynnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.